AstraZeneca selects N-SIDE Suite for Clinical Trials

N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement, AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain.

“N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across key areas of clinical development and deliver the best studies for our patients," John Murray, Supply Chain Transformation Lead at AstraZeneca, said.

AstraZeneca will achieve a centralization of their clinical supply chain management. The N-SIDE solution will support strategic decision-making during protocol design as well as operational planning and change management of on-going trials. The business intelligence dashboards will be used for real-time trial monitoring, results visualization and supporting cross-department communication.

"We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE Suite for Clinical Trials to manage their clinical supply chain” said Jacques Parlongue, N-SIDE CEO. N-SIDE has provided consulting services for AstraZeneca clinical trial supply optimization since 2017.

The N-SIDE Suite for Clinical Trials is a cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial monitoring with real-time data and knowledge sharing.

  • <<
  • >>